- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 7th, 2007
Nanoparticles - manufactured particles on the scale of atoms and molecules - are being developed to deliver drugs directly to cancer cells in the brain.
Right now, this system has been tested only on mice. Clinical trials involving people could begin within three years.
In order for most cancer drugs to be effective in the brain, they have to be administered in large doses. These toxic drugs kill the cancerous cells, but they also destroy healthy cells surrounding the tumor. Using nanotechnology, James Connor at Penn State University has devised a way to deliver smaller doses of drugs that target just cancerous cells using what's known as a "lipid-based nanoparticle."
|Related News Press|
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Seeing quantum motion August 30th, 2015
Draw out of the predicted interatomic force August 30th, 2015
Omni Nano and Time Warner Cable Partner to Provide Nanotechnology Education to the Boys & Girls Clubs of Los Angeles: A $10,000 Donation to Benefit Youth of Los Angeles County's Boys & Girls Clubs August 4th, 2015
Kalam: versatility personified August 1st, 2015